Nifty
Sensex
:
:
23850.90
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)

Healthcare Services - Diagnostic

Rating :
N/A

BSE: 539871 | NSE: THYROCARE

644.50
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  647.35
  •  663.00
  •  640.35
  •  645.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  166613
  •  1081.49
  •  985.00
  •  533.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,169.05
  • 61.56
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,115.12
  • 1.84%
  • 10.59

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.11%
  • 1.33%
  • 9.78%
  • FII
  • DII
  • Others
  • 1.93%
  • 13.98%
  • 1.87%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.07
  • 5.66
  • -0.97

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.68
  • -4.38
  • -10.06

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.58
  • -4.24
  • -26.21

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 39.19
  • 41.18
  • 40.69

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.29
  • 8.60
  • 6.97

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.66
  • 22.66
  • 20.52

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
177.36
148.00
19.84%
156.91
134.89
16.32%
154.25
135.88
13.52%
134.74
128.03
5.24%
Expenses
129.07
110.48
16.83%
114.27
100.38
13.84%
120.44
111.19
8.32%
103.15
100.17
2.97%
EBITDA
48.29
37.52
28.70%
42.64
34.51
23.56%
33.81
24.69
36.94%
31.59
27.86
13.39%
EBIDTM
27.23%
25.35%
27.17%
25.58%
21.92%
18.17%
23.45%
21.76%
Other Income
2.61
2.17
20.28%
3.62
0.98
269.39%
3.49
3.70
-5.68%
2.73
2.10
30.00%
Interest
0.76
1.13
-32.74%
0.99
0.88
12.50%
1.12
0.67
67.16%
1.07
0.58
84.48%
Depreciation
13.07
10.65
22.72%
11.36
9.83
15.56%
13.06
10.80
20.93%
13.47
10.15
32.71%
PBT
37.07
27.91
32.82%
33.91
24.78
36.84%
23.12
16.92
36.64%
19.78
19.23
2.86%
Tax
10.36
7.94
30.48%
9.61
7.65
25.62%
5.72
4.75
20.42%
5.17
5.02
2.99%
PAT
26.71
19.97
33.75%
24.30
17.13
41.86%
17.40
12.17
42.97%
14.61
14.21
2.81%
PATM
15.06%
13.49%
15.49%
12.70%
11.28%
8.96%
10.84%
11.10%
EPS
5.04
3.84
31.25%
4.56
3.27
39.45%
3.36
2.38
41.18%
2.90
2.78
4.32%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
623.26
571.88
526.67
588.86
494.62
434.26
402.91
356.32
304.39
240.97
182.96
Net Sales Growth
13.98%
8.58%
-10.56%
19.05%
13.90%
7.78%
13.08%
17.06%
26.32%
31.71%
 
Cost Of Goods Sold
181.44
166.70
163.23
169.69
163.90
117.09
110.53
94.98
81.42
70.35
55.83
Gross Profit
441.82
405.18
363.44
419.17
330.72
317.17
292.38
261.34
222.96
170.61
127.13
GP Margin
70.89%
70.85%
69.01%
71.18%
66.86%
73.04%
72.57%
73.34%
73.25%
70.80%
69.49%
Total Expenditure
466.93
433.11
404.14
353.13
323.36
260.69
248.75
211.69
189.03
146.92
110.29
Power & Fuel Cost
-
10.15
10.70
8.40
7.64
8.69
7.77
6.68
6.35
5.32
3.95
% Of Sales
-
1.77%
2.03%
1.43%
1.54%
2.00%
1.93%
1.87%
2.09%
2.21%
2.16%
Employee Cost
-
107.86
106.15
61.13
58.07
48.92
43.35
35.34
32.00
25.70
17.48
% Of Sales
-
18.86%
20.15%
10.38%
11.74%
11.27%
10.76%
9.92%
10.51%
10.67%
9.55%
Manufacturing Exp.
-
28.08
19.44
14.72
27.89
27.67
8.29
5.34
6.84
5.81
4.21
% Of Sales
-
4.91%
3.69%
2.50%
5.64%
6.37%
2.06%
1.50%
2.25%
2.41%
2.30%
General & Admin Exp.
-
106.96
91.90
83.69
58.28
49.31
74.33
63.70
58.42
37.60
27.22
% Of Sales
-
18.70%
17.45%
14.21%
11.78%
11.35%
18.45%
17.88%
19.19%
15.60%
14.88%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
13.36
12.72
15.50
7.58
9.01
4.48
5.65
3.98
2.13
0.00
% Of Sales
-
2.34%
2.42%
2.63%
1.53%
2.07%
1.11%
1.59%
1.31%
0.88%
0.87%
EBITDA
156.33
138.77
122.53
235.73
171.26
173.57
154.16
144.63
115.36
94.05
72.67
EBITDA Margin
25.08%
24.27%
23.27%
40.03%
34.62%
39.97%
38.26%
40.59%
37.90%
39.03%
39.72%
Other Income
12.45
9.36
8.42
29.25
12.43
6.67
10.13
23.26
12.29
6.54
8.11
Interest
3.94
5.53
4.83
3.21
0.87
1.85
0.61
0.44
0.46
0.55
0.30
Depreciation
50.96
47.01
38.71
33.87
30.28
31.91
26.17
20.10
18.05
18.24
12.87
PBT
113.88
95.59
87.41
227.90
152.54
146.48
137.51
147.35
109.14
81.80
67.62
Tax
30.86
26.49
24.23
51.58
39.32
52.01
52.92
51.71
38.83
30.00
23.58
Tax Rate
27.10%
27.71%
27.72%
22.63%
25.78%
37.18%
38.48%
35.62%
47.52%
36.67%
34.87%
PAT
83.02
70.76
64.49
176.14
113.22
87.89
84.59
93.45
42.88
51.80
45.22
PAT before Minority Interest
84.71
69.49
64.36
176.14
113.22
87.89
84.59
93.45
42.88
51.80
44.04
Minority Interest
1.69
1.27
0.13
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.18
PAT Margin
13.32%
12.37%
12.24%
29.91%
22.89%
20.24%
20.99%
26.23%
14.09%
21.50%
24.72%
PAT Growth
30.78%
9.72%
-63.39%
55.57%
28.82%
3.90%
-9.48%
117.93%
-17.22%
14.55%
 
EPS
15.66
13.35
12.17
33.23
21.36
16.58
15.96
17.63
8.09
9.77
8.53

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
526.76
534.30
526.57
427.28
366.65
435.12
443.29
407.81
365.61
276.37
Share Capital
52.95
52.93
52.90
52.87
52.84
52.79
53.72
53.69
53.72
50.54
Total Reserves
469.49
476.84
470.23
371.47
310.08
378.44
386.75
349.08
309.29
225.02
Non-Current Liabilities
10.95
148.69
105.98
17.79
20.51
13.87
10.18
8.61
10.10
8.67
Secured Loans
10.91
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
2.50
2.50
0.00
7.25
0.00
0.00
Long Term Provisions
3.06
143.86
96.17
13.58
8.16
6.72
5.33
5.15
6.82
3.16
Current Liabilities
90.49
77.09
215.26
95.10
81.69
20.59
20.30
17.62
31.41
7.30
Trade Payables
40.11
23.99
16.53
25.01
21.86
7.51
6.59
1.30
2.02
0.84
Other Current Liabilities
44.45
39.02
39.86
64.13
58.07
11.41
7.51
14.13
10.40
4.82
Short Term Borrowings
1.83
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
4.10
14.08
158.87
5.96
1.76
1.67
6.20
2.19
18.98
1.65
Total Liabilities
629.06
761.00
847.81
540.17
468.85
469.58
473.77
434.04
407.12
328.35
Net Block
305.88
293.89
284.95
253.06
269.09
294.30
298.75
258.67
259.10
196.01
Gross Block
501.12
461.10
422.59
365.93
359.08
355.40
336.04
276.72
318.18
237.06
Accumulated Depreciation
195.24
167.21
137.64
112.87
89.99
61.10
37.29
18.05
59.07
41.05
Non Current Assets
350.55
488.07
427.05
299.73
316.60
333.56
331.67
284.51
272.71
217.68
Capital Work in Progress
2.55
1.61
2.95
8.28
4.93
1.47
0.00
17.45
1.39
5.55
Non Current Investment
25.62
22.10
20.92
21.10
21.17
20.66
20.00
0.00
1.61
1.61
Long Term Loans & Adv.
15.45
169.40
113.48
14.16
18.32
16.89
12.69
8.23
10.60
14.50
Other Non Current Assets
1.05
1.07
4.75
3.13
3.09
0.24
0.23
0.16
0.00
0.00
Current Assets
278.51
272.93
420.76
240.44
152.25
136.02
142.10
149.53
134.40
110.67
Current Investments
136.75
122.30
125.21
104.49
69.03
74.64
100.10
104.16
91.63
84.30
Inventories
47.52
27.67
24.53
23.36
20.62
18.08
17.05
14.50
10.72
7.37
Sundry Debtors
43.47
85.11
93.20
44.68
16.30
12.16
9.54
6.28
7.50
4.91
Cash & Bank
39.89
28.47
13.91
15.73
11.07
9.60
11.86
11.79
10.29
5.08
Other Current Assets
10.88
3.11
2.44
47.66
35.23
21.54
3.55
12.80
14.26
9.01
Short Term Loans & Adv.
7.49
6.27
161.47
4.52
2.82
1.66
1.87
7.56
6.85
6.61
Net Current Assets
188.02
195.84
205.50
145.34
70.56
115.43
121.80
131.91
103.00
103.37
Total Assets
629.06
761.00
847.81
540.17
468.85
469.58
473.77
434.04
407.11
328.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
167.63
129.31
113.41
114.73
167.88
100.31
107.03
89.57
67.80
34.46
PBT
95.59
87.41
227.90
152.54
146.48
137.40
144.99
81.67
81.80
67.62
Adjustment
70.87
64.57
21.49
23.05
32.13
24.17
8.78
42.79
17.06
6.50
Changes in Working Capital
30.16
5.79
-79.22
-17.65
33.78
-0.65
2.17
5.57
0.87
-16.86
Cash after chg. in Working capital
196.62
157.77
170.17
157.94
212.39
160.92
155.94
130.03
99.72
57.25
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-28.99
-28.46
-56.76
-43.21
-44.51
-60.61
-48.91
-40.46
-31.92
-22.79
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-91.28
-38.99
-23.57
-48.66
0.95
-11.59
-43.22
-41.52
-17.68
-17.96
Net Fixed Assets
-22.85
-31.34
-45.84
-30.21
-24.29
-20.96
-22.71
29.40
-17.12
Net Investments
-17.52
-14.55
14.42
-34.44
49.94
25.46
-15.94
-33.05
-103.31
Others
-50.91
6.90
7.85
15.99
-24.70
-16.09
-4.57
-37.87
102.75
Cash from Financing Activity
-84.81
-86.18
-89.41
-61.58
-164.78
-93.63
-63.87
-48.52
-44.96
-22.84
Net Cash Inflow / Outflow
-8.46
4.14
0.43
4.49
4.05
-4.91
-0.06
-0.46
5.17
-6.34
Opening Cash & Equivalents
17.76
13.63
13.20
8.71
4.91
9.82
9.88
10.35
5.08
11.42
Closing Cash & Equivalent
9.30
17.77
13.63
13.20
8.96
4.91
9.82
9.88
10.24
5.08

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
98.67
100.09
98.89
80.26
68.68
81.69
81.99
75.02
67.57
54.53
ROA
10.00%
8.00%
25.38%
22.44%
18.73%
17.93%
20.59%
10.20%
14.09%
13.41%
ROE
13.21%
12.23%
37.18%
28.76%
22.13%
19.41%
22.16%
11.20%
16.22%
15.98%
ROCE
18.75%
17.61%
48.42%
38.52%
35.14%
31.36%
33.93%
21.05%
25.66%
24.57%
Fixed Asset Turnover
1.19
1.19
1.49
1.36
1.22
1.17
1.16
1.02
0.87
0.77
Receivable days
41.03
61.79
42.73
22.50
11.96
9.83
8.10
8.26
9.40
9.80
Inventory Days
23.99
18.09
14.84
16.23
16.26
15.91
16.16
15.12
13.70
14.70
Payable days
70.18
45.30
44.68
52.19
45.78
13.10
8.88
4.17
4.18
3.23
Cash Conversion Cycle
-5.15
34.57
12.90
-13.46
-17.55
12.64
15.38
19.21
18.92
21.27
Total Debt/Equity
0.04
0.00
0.00
0.00
0.01
0.01
0.00
0.02
0.00
0.00
Interest Cover
18.36
19.34
71.94
176.33
76.62
226.43
330.91
177.48
149.46
226.39

News Update:


  • Thyrocare Tech. - Quarterly Results
    23rd Oct 2024, 16:20 PM

    Read More
  • Thyrocare Technologies acquires business of Polo
    30th Jul 2024, 10:14 AM

    Earlier, the company had executed BTA with Polo to acquire Polo’s diagnostic and pathological services business

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.